CO-MPEG-LA
MPEG LA announced today that Huawei Technologies Co., Ltd., Huawei Device Co., Ltd and Huawei Device (Shenzhen) Co., Ltd (“Huawei”) have become Licensees to MPEG LA’s AVC Patent Portfolio License (“AVC License”).
As a result of this agreement, all legal disputes related to patent enforcement actions brought by patent holders in MPEG LA’s AVC License against Huawei have been resolved. See https://www.mpegla.com/wp-content/uploads/2018/12/FINAL-Huawei-ZTE-Infringement-PrsRls-2018-11-16.pdf ; and https://www.mpegla.com/wp-content/uploads/2019/02/FINAL-PrsRls-2018-12-27.pdf .
MPEG LA, LLC
MPEG LA is the world’s leading provider of one-stop licenses for standards and other technology platforms. Starting in the 1990s, it pioneered the modern-day patent pool helping to produce the most widely used standards in consumer electronics history. MPEG LA has operated licensing programs for a variety of technologies consisting of nearly 20,000 patents in 90 countries with more than 250 patent holders and more than 6,000 licensees. Approximately 2,000 licensees enjoy the worldwide one-stop coverage of MPEG LA’s AVC Patent Portfolio License under essential patents owned by 38 patent holders. By assisting users with implementation of their technology choices, MPEG LA offers licensing solutions that provide access to fundamental intellectual property, freedom to operate, reduced litigation risk and predictability in the business planning process. For more information, go to www.mpegla.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190219005131/en/
Contact:
Tom O’Reilly MPEG LA, LLC Tel: 303.200.1710 toreilly@mpegla.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KINAXIS-INC.26.4.2024 18:04:28 CEST | Press release
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions
VERTEX-PHARMA26.4.2024 17:44:28 CEST | Press release
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
SUZANO-S.A.26.4.2024 17:23:27 CEST | Press release
Suzano 2023 annual report on Form 20-F
MA-TAKEDA-PHARMACEUTICAL26.4.2024 14:31:34 CEST | Press release
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
WOLTERS-KLUWER26.4.2024 14:01:34 CEST | Press release
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom